Milad Iranshahy

Milad Iranshahy

Auto-generated profile, based on publicly available information

Milad Iranshahy

Mashhad University of Medical Science, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2020 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EAEsmaeil Sheikh Ahmadi
Esmaeil Sheikh Ahmadi
ATAmir Tajbakhsh
Amir Tajbakhsh
MIMilad Iranshahy
Milad Iranshahy
JAJavad Asili
Javad Asili
Nadine KretschmerNadine Kretschmer
Nadine Kretschmer
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar
Naturally occurring naphthoquinones (NQs) comprising highly reactive small molecules are the subject of increasing attention due to their promising biological activities such as antioxidant, antimicrobial, apoptosis-inducing activities, and especially anticancer activity. Lapachol, lapachone, and napabucasin belong to the NQs and are in phase II clinical trials for the treatment of many cancers. This review aims to provide a comprehensive and updated overview on the biological activities of several new NQs isolated from different species of plants reported from January 2013 to January 2020, their potential therapeutic applications and their clinical significance.

13 June 2023 in Archives of Medical Science
Verified
Journal Article
Open access
SGShiva Ganjali
Shiva Ganjali
MRMaryam Matbou Riahi
Maryam Matbou Riahi
Khadijeh MahboobniaKhadijeh Mahboobnia
Khadijeh Mahboobnia
MIMilad Iranshahy
Milad Iranshahy
Maciej BanachMaciej Banach
Maciej Banach
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar
Introduction: -Material and methods: The possible role of Urolithin A (UA) and Urolithin B (UB) on the induction of LDL uptake and the expression of its regulatory genes was eexplored using HepG2 cells and curcumin (20 uM), berberine (50 uM), UA (80 uM), and UB (80 uM) as the treatments in the experimental tests.Results: The LDL uptake as well as cell-surface LDLR were higher in cells treated with UA in compari-son with cells treated with UB, and even in relation to the cells treated with curcumin and ber-berine as positive controls. In addition, cells treated with UB showed approximately 2 times greater LDLR expression levels compared with curcumin (FC: 2.144, P=0.013) and berberine (FC: 2.761, P=0.006). However, UA treatment resulted in significantly lower expression levels of LDLR compared with curcumin (FC: 0.274, P<0.001) and berberine (FC: 0.352, P=0.009). UB demonstrated approximately 8 times greater LDLR expression levels when compared with UA (FC:7.835, P=0.001). Compared with UB, as well as curcumin and berberine as positive controls, UA was more efficient in reducing PCSK9 expression levels. Although UB did not show any significant differences compared with curcumin and berberine, it illustrated higher levels of PCSK9 expression when compared with the UA group (FC: 3.694, P<0.001).Conclusions: The present results support that UA was more effective than UB in promoting LDL uptake as well as cell surface LDLR in HepG2 cells. This effect seems to be mostly mediated through the sup-pression of PCSK9 expression but not the induction of LDLR expression.